Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Merck Tbk. (MERK) vs Phapros Tbk. (PEHA)

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Merck Tbk. dan Phapros Tbk.: Merck Tbk. diperdagangkan di Rp3.900 (kapitalisasi pasar 1,76 T, volume 24 jam 63 rb), sedangkan Phapros Tbk. diperdagangkan di Rp298 (kapitalisasi pasar 250,32 M, volume 24 jam 116,6 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 7× kapitalisasi pasar Phapros Tbk., dan Phapros Tbk. lebih aktif diperdagangkan (116,6 rb vs 63 rb). Mana yang lebih baik tergantung tujuan investasimu.

MERKPEHA
Kapitalisasi Pasar
1,76 T250,32 M
Volume
63 rb116,6 rb
Lot
6301,17 rb
Perputaran
243,97 jt34,22 jt
Harga Rata-rata
3.872,46293,45
Nilai Transaksi
243,97 jt34,22 jt
Harga Ekuilibrium Indikatif
3.900300
Volume Ekuilibrium Indikatif
17

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

MERK
Lihat detail
PEHA
Lihat detail

Tentang Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Selengkapnya di halaman MERK

Tentang Phapros Tbk.

PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.

Selengkapnya di halaman PEHA